NASDAQ:DFTX | Free Cash Flow | Definium Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$42.63M
2025-12-31-$42.98M
2025-03-31-$29.42M
2024-12-31-$25.35M
2024-03-31-$16.6M
2023-12-31-$20.56M
2023-03-31-$13.33M
2022-12-31-$12.85M
2022-03-31-$12.87M
2021-12-31-$7.83M
2021-03-31-$10.04M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$131.56M
2024-12-31-$79.13M
2023-12-31-$64.37M
2022-12-31-$50.14M
2021-12-31-$45.82M
2020-12-31-$23.6M